- Report
- August 2024
- 66 Pages
Global
From €1120EUR$1,250USD£954GBP
- Report
- May 2025
- 185 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 189 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 180 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- August 2024
- 100 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- May 2025
- 196 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 183 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 187 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 72 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 172 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 84 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 64 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 193 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 285 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 278 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 282 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- October 2024
- 180 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Training
- March 2025
- 2 Days
Global
From €1430EUR$1,597USD£1,219GBP
- Training
- July 2025
- 2 Days
Global
From €1395EUR$1,558USD£1,189GBP

Quality by Design (QbD) is a systematic approach to pharmaceutical manufacturing that focuses on product and process understanding, design, and control. It is based on the principles of risk management and quality assurance, and is intended to ensure that products meet their intended quality, safety, and efficacy requirements. QbD is a holistic approach to product development that involves the integration of product and process design, development, and control. It is a proactive approach to product development that seeks to identify and address potential risks before they become problems.
QbD is becoming increasingly important in the pharmaceutical industry, as it helps to ensure that products are safe and effective. It also helps to reduce costs associated with product development and manufacturing, as well as improve product quality and consistency.
Some companies in the QbD market include Merck, Pfizer, Novartis, GlaxoSmithKline, AstraZeneca, and Sanofi. Show Less Read more